Tara Ravi

Overview

A unique background in healthcare that includes clinical, academic and regulatory experience has made Tara Ravi an exceptionally well-rounded counselor to healthcare organizations facing reimbursement or regulatory challenges. Her solutions-oriented strategies and problem-solving communication style help her clients reach successful resolutions with state and federal agencies and achieve compliant and cost-efficient outcomes during corporate growth and expansion.

Clients rely on Tara to navigate through complex regulatory issues such as Medicare, Medicaid and managed care reimbursement and enrollment as well as federal and state licensure. She helps clients identify, assess and mitigate risks and, when necessary, provides experienced counsel regarding investigations and self-disclosures to the Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services Office of Inspector General and the U.S. Department of Justice, among other agencies.

Tara also helps healthcare organizations poised for expansion, with a special focus on solutions for efficient multi-jurisdictional growth across complex state and federal regulatory and reimbursement frameworks. Tara’s expertise is highly valued both before and after complex transactions, where she is called upon to create and implement corporate compliance programs, address government and private payor continuity issues across jurisdictions, and structure management arrangements to comply with state corporate practice regulations. Tara additionally leverages this experience to assist healthcare lenders with their healthcare due diligence needs and regularly presents on healthcare issues related to asset-based lending.

Experience

Assisted in the defense of regional Florida health system in False Claims Act qui tam alleging violations of the Stark Law relating to the provision of oncology services.*
Prepared winning argument securing dismissal of whistleblower claims in a False Claims Act qui tam suit alleging that former employer radiology group practice failed to enroll as an independent diagnostic testing facility.*
Assisted in the negotiation of False Claims Act settlement with the DOJ relating to claims of improper supervision of radiation oncology services.*
Represented a multi-national pharmaceutical company in connection with a DOJ investigation into its patient support program, drug pricing, and specialty pharmacy issues.*
Developed company-wide compliance training materials, as well as department-specific materials (including sales and marketing) for a multi-national medical device company.*
Healthcare regulatory counsel on team representing Georgia healthcare system's acquisition of five metro Atlanta hospitals.*
Healthcare regulatory counsel on team representing Georgia hospital system's merger with a regional healthcare system.*
Lead regulatory counsel in the $2.2 billion sale of a publicly traded healthcare services company to a large private equity company.*
Lead regulatory counsel on team that represented a multinational investment bank as lead arrangers for the financing of a large private equity firm's $950 million acquisition and merger of the now-largest pediatric home healthcare company in the U.S.*

* Denotes experience prior to joining Parker Hudson.

thought leadership

Presenter: Sex, Drugs and Telehealth, Hot Topics in Healthcare CLE, The Florida Bar Health Law Section (May 15, 2020)
Presenter: Studying the New Health System and Private Equity Playbooks, AHLA Health Care Transaction Conference (April 21, 2020) (co-presenting with Kristen McDermott Woodrum)
Presenter: Taking Advantage of Medicare Advantage Plans, North Carolina Healthcare Financial Management Association Annual Conference (March 4, 2020)
Presenter: Regulatory Forecast for Hot Healthcare Investments, ACG Chicago Healthcare M&A Conference with DealSource (May 21, 2019)
Webinar: Healthcare Issues in Asset Based Lending (May 8, 2019)
Co-Author: Women Investing in Women's Health: The Rise of Femtech Companies and Investors in Celebration of Women's History Month, Lexology (March 19, 2019) (co-authored with Jessie Gabriel)
Author: OIG 2017 Work Plan—The New and the Familiar, Health Law Developments, State Bar of Georgia (Spring 2017)
Author: CMS Takes Lead in Cardiology Payment Reform, Lexology (Jul. 22, 2016)
Co-Author: Olympus: Another Life Sciences Company Gets Hit Hard, Law360 (Mar. 21, 2016) (co-authored with Gary Giampetruzzi and Zachary Zwillinger) (reprinted as Law360’s “10 Most Read Expert Analyses” on March 26, 2016 in “In Case You Missed It: Hottest Firms And Stories On Law360.”)
Co-Author: IRS Ruling Spells Good News for Captive PCs, Law360 (Feb. 20, 2015) (co-authored with Phillip H. Street, Michael D. Haun, and W. Craig Smith)
Co-Author: Hospitals and Physician Bonus Pools: Improper Designs Prompt Penalties Over $100 Million, Lexology (Feb. 4, 2015) (co-authored with Phillip Street, J. Mark Poerio, and W. Craig Smith)
Co-Author: The Responsible Corporate Officer Doctrine: Status and Liability (co-authored with Gabriel L. Imperato, Esq.)
Compliance Today (May 2012)
Co-Author: CMS Proposes Regulations Implementing the Mandatory 60-Day Overpayment Disclosure Requirement (co-authored with Lester J. Perling, Esq.) South Florida Hospital News (Apr. 2012)
Author: HITECH Act Earmarks $17 Billion for “Meaningful Use” of Electronic Records to Improve Health Care Quality and Delivery, South Florida Hospital News (Jun. 2010)
Co-Author: John Brumfield, Michelle LaPlaca, Felicia Goldstein, Patrick Kilgo, Tara Ravichandran, Melissa Danielson & David Wright, Use of a Novel Technology to Detect Mild Cognitive Impairment in Elder Patients, 14 Acad. Emergency Med. 152 (Supp. 2007); reprinted in 64 Int. J. Clin. Pract., 9, 1190-1197 (Aug.2010)
Co-Author: Chunchun Ni, Hui Mao, Felicia Goldstein, Tara Ravichandran & Randall Scheibel, Changes of White Matter Integrity and Brain Activation in Diffuse Brain Injuries: Assessed by fMRI and DTI (May 6, 2006) (on file with The Emory University School of Medicine)